Published in Naunyn Schmiedebergs Arch Pharmacol on September 19, 2003
Loss of NHE1 activity leads to reduced oxidative stress in heart and mitigates high-fat diet-induced myocardial stress. J Mol Cell Cardiol (2013) 0.84
Alkali therapy attenuates the progression of kidney injury via Na/H exchanger inhibition in 5/6 nephrectomized rats. J Korean Med Sci (2014) 0.77
NHE1 deficiency in liver: implications for non-alcoholic fatty liver disease. Biochem Biophys Res Commun (2014) 0.75
A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem (1985) 2.46
The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions. Annu Rev Pharmacol Toxicol (2002) 2.15
Na+/H+ exchangers of mammalian cells. J Biol Chem (1997) 2.12
NHE3: a Na+/H+ exchanger isoform of renal brush border. Am J Physiol (1993) 1.93
NHE2 and NHE3 are human and rabbit intestinal brush-border proteins. Am J Physiol (1996) 1.84
Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice. Circ Res (2002) 1.79
The expanding family of eucaryotic Na(+)/H(+) exchangers. J Biol Chem (2000) 1.72
Intracellular pH regulation by Na(+)/H(+) exchange requires phosphatidylinositol 4,5-bisphosphate. J Cell Biol (2000) 1.52
Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res (1995) 1.51
Identification of a mitochondrial Na+/H+ exchanger. J Biol Chem (1998) 1.48
A novel topology model of the human Na(+)/H(+) exchanger isoform 1. J Biol Chem (2000) 1.44
Human Na(+)/H(+) exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria. Am J Physiol Cell Physiol (2002) 1.41
Pharmacological characterization of stably transfected Na+/H+ antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties. Mol Pharmacol (1993) 1.38
The myocardial Na(+)-H(+) exchange: structure, regulation, and its role in heart disease. Circ Res (1999) 1.34
Renal expression of novel Na+/H+ exchanger isoform NHE8. Am J Physiol Renal Physiol (2002) 1.28
Acute regulation of proximal tubule apical membrane Na/H exchanger NHE-3: role of phosphorylation, protein trafficking, and regulatory factors. J Am Soc Nephrol (1999) 1.27
Molecular cloning and characterization of a novel (Na+,K+)/H+ exchanger localized to the trans-Golgi network. J Biol Chem (2001) 1.23
Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists. Am J Cardiol (1999) 1.18
Cloning and expression of a rabbit cDNA encoding a serum-activated ethylisopropylamiloride-resistant epithelial Na+/H+ exchanger isoform (NHE-2). J Biol Chem (1993) 1.17
The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol (2001) 1.16
Regulation of intracellular pH in cultured hippocampal neurons by an amiloride-insensitive Na+/H+ exchanger. J Biol Chem (1991) 1.13
The p42/p44 mitogen-activated protein kinase cascade is determinant in mediating activation of the Na+/H+ exchanger (NHE1 isoform) in response to growth factors. J Biol Chem (1997) 1.10
Na(+)/H(+) exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Coll Cardiol (2002) 1.10
Increased Na+/H+-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc Res (2003) 1.10
p38 Kinase is a negative regulator of angiotensin II signal transduction in vascular smooth muscle cells: effects on Na+/H+ exchange and ERK1/2. Circ Res (1998) 1.08
The Na+/H+ exchanger gene family. J Nephrol (2002) 1.05
Thrombin activates the sarcolemmal Na(+)-H+ exchanger. Evidence for a receptor-mediated mechanism involving protein kinase C. Circ Res (1996) 1.05
Attenuation of compensatory right ventricular hypertrophy and heart failure following monocrotaline-induced pulmonary vascular injury by the Na+-H+ exchange inhibitor cariporide. J Pharmacol Exp Ther (2001) 1.04
Calmodulin-binding autoinhibitory domain controls "pH-sensing" in the Na+/H+ exchanger NHE1 through sequence-specific interaction. Biochemistry (1997) 1.03
Molecular cloning, genomic organization, and functional expression of Na+/H+ exchanger isoform 5 (NHE5) from human brain. J Biol Chem (1999) 1.02
Tissue distribution of Na+/H+ exchanger isoforms NHE2 and NHE4 in rat intestine and kidney. Am J Physiol (1997) 0.99
Protein kinase-mediated regulation of the Na(+)/H(+) exchanger in the rat myocardium by mitogen-activated protein kinase-dependent pathways. J Biol Chem (1999) 0.99
Protection of the ischaemic myocardium by Na+/H+ exchange inhibitors: potential mechanisms of action. Basic Res Cardiol (2001) 0.98
Na(+)/H(+)exchangers: linking osmotic dysequilibrium to modified cell function. Cell Physiol Biochem (2001) 0.98
A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo. J Pharmacol Exp Ther (2001) 0.96
Sodium-hydrogen exchange inhibition during ventricular fibrillation: Beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Circulation (2003) 0.96
Inhibition of the Na(+)/H(+) exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs. Circulation (2000) 0.94
Na(+)/H(+) exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats. Am J Physiol Heart Circ Physiol (2001) 0.93
Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation (1997) 0.93
Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642). Clin Exp Hypertens (1998) 0.93
Activation of Na+/H+ exchanger-directed protein kinases in the ischemic and ischemic-reperfused rat myocardium. J Biol Chem (2001) 0.90
The Na-H exchanger revisited: an update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease. Cardiovasc Res (1997) 0.90
Phosphorylation and regulation of the Na+/H+ exchanger through mitogen-activated protein kinase. Biochemistry (1997) 0.89
Regression of cardiomyocyte hypertrophy in SHR following chronic inhibition of the Na(+)/H(+) exchanger. Cardiovasc Res (2002) 0.88
Regression of hypertensive myocardial fibrosis by Na(+)/H(+) exchange inhibition. Hypertension (2003) 0.87
Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1. Crit Care Med (2002) 0.86
Na(+)/H(+) exchange inhibition attenuates hypertrophy and heart failure in 1-wk postinfarction rat myocardium. Am J Physiol Heart Circ Physiol (2000) 0.86
Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium. Diabetes Metab Res Rev (2002) 0.86
Role of ion channels and exchangers in mechanical stretch-induced cardiomyocyte hypertrophy. Circ Res (1998) 0.85
Activation of Na(+)-H+ antiporter (NHE-1) gene expression during growth, hypertrophy and proliferation of the rabbit cardiovascular system. J Mol Cell Cardiol (1995) 0.85
Influence of endothelin 1 on human atrial myocardium--myocardial function and subcellular pathways. Basic Res Cardiol (1996) 0.85
Calcium and osmotic regulation of the Na+/H+ exchanger in neonatal ventricular myocytes. J Mol Cell Cardiol (2000) 0.84
Inhibition of the Na(+)/H(+) exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation. Eur J Pharmacol (2000) 0.84
Effects of cariporide and losartan on hypertrophy, calcium transients, contractility, and gene expression in congestive heart failure. Circulation (2002) 0.84
Effects of inhibiting Na(+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling. Cardiovasc Res (2002) 0.84
Differential effects of angiotensin AT1 and AT2 receptors on the expression, translation and function of the Na+-H+ exchanger and Na+-HCO3- symporter in the rat heart after myocardial infarction. J Am Coll Cardiol (2001) 0.84
Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition. Circ Res (2000) 0.83
Induction of expression of the sodium-hydrogen exchanger in rat myocardium. Cardiovasc Res (1995) 0.83
Characterization of sabiporide, a new specific NHE-1 inhibitor exhibiting slow dissociation kinetics and cardioprotective effects. Eur J Pharmacol (2003) 0.83
Effects of the Na+/H+ exchange inhibitor cariporide (HOE 642) on cardiac function and cardiomyocyte cell death in rat ischaemic-reperfused heart. Clin Exp Pharmacol Physiol (2000) 0.82
Potent and selective inhibition of the human Na+/H+ exchanger isoform NHE1 by a novel aminoguanidine derivative T-162559. Eur J Pharmacol (2001) 0.82
Glucose metabolism, H+ production and Na+/H+-exchanger mRNA levels in ischemic hearts from diabetic rats. Mol Cell Biochem (1998) 0.81
Adenosine A(1) receptor stimulation inhibits alpha(1)-adrenergic activation of the cardiac sarcolemmal Na(+)/H(+) exchanger. Br J Pharmacol (2000) 0.81
Role of sodium-hydrogen exchange in cardiac hypertrophy and heart failure: a novel and promising therapeutic target. Basic Res Cardiol (2001) 0.80
NHE1-inhibitor cariporide prevents the transient reperfusion-induced shortening of the monophasic action potential after coronary ischemia in pigs. Basic Res Cardiol (2001) 0.80
Na(+)/H(+) exchange inhibitor cariporide attenuates cell injury predominantly during ischemia and not at onset of reperfusion in porcine hearts with low residual blood flow. Circulation (2000) 0.80
High-performance liquid chromatographic analysis of free hydroxyproline and proline in blood plasma and of free and peptide-bound hydroxyproline in urine. J Chromatogr (1985) 0.79
A 90-kD Na(+)-H+ exchanger kinase has increased activity in spontaneously hypertensive rat vascular smooth muscle cells. Hypertension (1997) 0.79
Regulation of cardiac sarcolemmal Na+/H+ exchanger activity: potential pathophysiological significance of endogenous mediators and oxidant stress. J Thromb Thrombolysis (1999) 0.79
Heterotrimeric G proteins in heart disease. Can J Physiol Pharmacol (2000) 0.79
Myocardial protection during ventricular fibrillation by reduction of proton-driven sarcolemmal sodium influx. J Lab Clin Med (2001) 0.79
The effect of an Na+/H+ exchange inhibitor, SM-20550, on ischemia/reperfusion-induced endothelial dysfunction in isolated perfused rat hearts. Int J Tissue React (2001) 0.79
Bradykinin B1 and B2 receptors differentially regulate cardiac Na+-H+ exchanger, Na+-Ca2+ exchanger and Na+-HCO3- symporter. Eur J Pharmacol (2003) 0.79
Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1). Cardiovasc Drug Rev (2003) 0.79
Na/H exchange isoform 1 is involved in mineralocorticoid/salt-induced cardiac injury. Hypertension (2003) 0.79
Pharmacokinetic/pharmacodynamic evaluation of the NHE inhibitor eniporide. J Clin Pharmacol (2001) 0.78
Aldosterone modulates both the Na/H antiport and Cl/HCO3 exchanger in cultured neonatal rat cardiac cells. J Mol Cell Cardiol (1995) 0.78
Do NHE inhibition and ischemic preconditioning convey cardioprotection through a common mechanism? Basic Res Cardiol (2001) 0.78
Pharmacological profile of SL 59.1227, a novel inhibitor of the sodium/hydrogen exchanger. Br J Pharmacol (2000) 0.77
Pharmacological analysis by HOE642 and KB-R9032 of the role of Na(+)/H(+) exchange in the endothelin-1-induced Ca(2+) signalling in rabbit ventricular myocytes. Br J Pharmacol (2000) 0.77
Cardioprotective effects of the Na(+)/H(+)-exchange inhibitor cariporide in infarct-induced heart failure. Cardiovasc Res (2000) 0.77
Pharmacological interference with the cardiac renin-angiotensin system. J Cardiovasc Pharmacol (1989) 0.77
Influence of pHi and creatine phosphate on alpha-adrenoceptor-mediated cardiac hypertrophy. J Mol Cell Cardiol (1998) 0.77
Effective protection by NHE-1 inhibition in ischemic and reperfused heart under preconditioning blockade. Am J Physiol Heart Circ Physiol (2003) 0.77
Hypertrophic responsiveness of cardiomyocytes to alpha- or beta-adrenoceptor stimulation requires sodium-proton-exchanger-1 (NHE-1) activation but not cellular alkalization. Eur J Heart Fail (2002) 0.76
Functional and cellular regulation of the myocardial Na+/H+ exchanger. J Thromb Thrombolysis (1999) 0.76
Modulation of Na+/H+ exchange isoform 1 mRNA expression in isolated rat hearts. Am J Physiol (1999) 0.76
Na+/H+ exchange hyperactivity and myocardial hypertrophy: are they linked phenomena? Cardiovasc Res (1999) 0.75
MRI/MRS evaluation of cariporide in a canine long-term model of reperfused ischemic insults. Magnetic resonance imaging/magnetic resonance spectroscopy. J Magn Reson Imaging (2003) 0.75
Development of the Na+/H+ exchange inhibitor cariporide as a cardioprotective drug: from the laboratory to the GUARDIAN trial. J Thromb Thrombolysis (1999) 0.75
Inhibition of the Na(+)/H(+) exchanger delays the development of rapid pacing-induced atrial contractile dysfunction. Circulation (2001) 0.75
Effects of Na(+)-H+ exchange blocker amiloride on left ventricular remodeling after anterior myocardial infarction in rats. Cardiovasc Drugs Ther (1995) 0.75
GUARD During Ischemia Against Necrosis (GUARDIAN) trial in acute coronary syndromes. Am J Cardiol (1999) 0.75
Molecular basis for Kv1.5 channel block: conservation of drug binding sites among voltage-gated K+ channels. J Biol Chem (2003) 1.30
Chromanol 293B binding in KCNQ1 (Kv7.1) channels involves electrostatic interactions with a potassium ion in the selectivity filter. Mol Pharmacol (2007) 1.24
Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase. Mol Pharmacol (2005) 1.17
Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces I(Ca,L) and I(to) in rapid atrial pacing in rabbits. J Am Coll Cardiol (2003) 1.11
Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling. Circulation (2008) 1.10
Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats. Cardiovasc Res (2003) 1.07
C-terminal interaction of KCNQ2 and KCNQ3 K+ channels. J Physiol (2003) 1.05
Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs. Cardiovasc Res (2003) 0.93
Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent. Br J Pharmacol (2004) 0.91
Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide. Naunyn Schmiedebergs Arch Pharmacol (2002) 0.90
Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs. Med Sci Monit (2004) 0.89
Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation. Eur J Pharmacol (2004) 0.88
Dietary bread crust advanced glycation end products bind to the receptor for AGEs in HEK-293 kidney cells but are rapidly excreted after oral administration to healthy and subtotally nephrectomized rats. Ann N Y Acad Sci (2005) 0.87
The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia. Br J Pharmacol (2002) 0.87
Impaired left ventricular relaxation in type 2 diabetic rats is related to myocardial accumulation of N(epsilon)-(carboxymethyl) lysine. Eur J Heart Fail (2005) 0.85
Fluid shear stress differentially regulates gpr3, gpr6, and gpr12 expression in human umbilical vein endothelial cells. Cell Physiol Biochem (2003) 0.82
RAGE-mediated MAPK activation by food-derived AGE and non-AGE products. Biochem Biophys Res Commun (2003) 0.82
Chronic vasopeptidase inhibition normalizes diabetic endothelial dysfunction. Eur J Pharmacol (2004) 0.82
Comparative analysis of human and rat S1P(5) (edg8): differential expression profiles and sensitivities to antagonists. Biochem Pharmacol (2002) 0.79
Effect of chronic treatment with the vasopeptidase inhibitor AVE 7688 and ramipril on endothelial function in atherogenic diet rabbits. J Renin Angiotensin Aldosterone Syst (2003) 0.79
Effects of combined inhibition of the Na+-H+ exchanger and angiotensin-converting enzyme in rats with congestive heart failure after myocardial infarction. Br J Pharmacol (2005) 0.78
Inhibition of cardiac potassium currents by pentobarbital. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.78
Inhibition of Na+-H+ exchange by cariporide reduces inflammation and heart failure in rabbits with myocardial infarction. Br J Pharmacol (2004) 0.77
Long term Rho-kinase inhibition ameliorates endothelial dysfunction in LDL-Receptor deficient mice. Eur J Pharmacol (2005) 0.76
Effects of acute and chronic treatment with the sodium hydrogen exchanger 1 (NHE-1) inhibitor cariporide on myocardial infarct mass in rabbits with hypercholesterolaemia. Basic Clin Pharmacol Toxicol (2004) 0.75
Down-regulation of calpain 9 is linked to hypertensive heart and kidney disease. Cell Physiol Biochem (2005) 0.75
[Management of high blood pressure and cardiac insufficiency. New drugs and therapeutic concepts]. Pharm Unserer Zeit (2003) 0.75
[Intervention in the renin-angiotensin and kallikrein-kinin systems. Pharmacologic basis of the action of ACE inhibitors]. Pharm Unserer Zeit (2003) 0.75